AVANIR PHARMACEUTICALS
S-8, EX-23.1, 2000-05-30
PHARMACEUTICAL PREPARATIONS
Previous: AVANIR PHARMACEUTICALS, S-8, EX-5.1, 2000-05-30
Next: NATIONS INSTITUTIONAL RESERVES, NSAR-B, 2000-05-30



<PAGE>   1


                                                                    EXHIBIT 23.1

                          INDEPENDENT AUDITOR'S CONSENT

AVANIR Pharmaceuticals:

We consent to the incorporation by reference in this Registration Statement of
AVANIR Pharmaceuticals, (a development stage enterprise) (the "Company") on Form
S-8 of our report dated December 21, 1999 (which report expresses an unqualified
opinion and includes explanatory paragraphs relating to the status of the
Company as a development stage enterprise, the Company's ability to continue as
a going concern, and the Company as a defendant in certain lawsuits), appearing
in the Annual Report on Form 10-K of AVANIR Pharmaceuticals for the year ended
September 30, 1999.

DELOITTE & TOUCHE LLP

San Diego, California
May 30, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission